usedtobeperkytina
Senior Member
- Messages
- 1,479
- Location
- Clay, Alabama
Sing, well, I don't than the mice. Retrovirologists say they gave us this tricky virus.
Tina
Tina
Collaborators on this research are Dr. Frank Ruscetti, Laboratory of Experimental Immunology, CCR, NCI; Dr. Larry Keefer, Laboratory of Comparative Carcinogenesis, CCR, NCI; Dr. Judy Mikovits, Whittemore Peterson Institute; Drs. Candace Pert and Michael Ruff, RAPID Pharmaceuticals.
From Wikipedia: She holds a number of patents for modified peptides in the treatment of psoriasis, Alzheimer's disease, chronic fatigue syndrome, stroke and head trauma. One of these, Peptide T, had been considered for the treatment of AIDS and neuroAIDS. The results of a placebo-controlled, three site, 200+ patient NIH-funded clinical trial which focused on neurocognitive improvements, was conducted between 1990 and 1995. The results showed that Peptide T was not significantly different from placebo on the study primary end points, tests of brain function. However Peptide T was associated with improved performance (memory and learning) in the subgroup of patients with more severe cognitive impairment.
Holy Smokes, George! Thank you for posting this, about the work going on using mice and studying their responses to their version of XMRV. Maybe this is off topic for some people, but I want to acknowledge and thank mice spiritually, for their help, in speeding the information we need to be diagnosed and treated for XAND illnesses.
Sing
Sing, well, I don't than the mice. Retrovirologists say they gave us this tricky virus.
Tina
dmarie4301 has started a thread about Ruscetti's research (as quoted by George) here:
http://forums.aboutmecfs.org/showth...out-NIH-and-XMRV-treatments&p=50075#post50075
Hmm... Ruscetti... 'scetti.... coincidence??
We are currently using knowledge and reagents obtained from working with mouse retroviruses to study the xenotropic MuLV-related human retrovirus XMRV, which was recently discovered through an association with prostate cancer. In collaboration with the laboratories of Judy Mikovits and Frank Ruscetti, we were able to use antibodies developed against the envelope protein of SFFV to detect infectious XMRV in the blood cells and plasma of patients suffering from the neuroimmune disease chronic fatigue syndrome (CFS).
Here are some thoughts that Dr. Mikovitz communicated to a source which I have paraphrased. This is third hand information. (Obviously, this does not carry the weight of “Dr. Mikovitz said,” but I believe it to be an accurate reflection of her current thinking.) I have permission to post.
It may be possible for some to have an immune defect that prevents them from expressing antibodies at all. They would then require culture testing, or possibly tissue biopsy to find the infection.
Gracenote had you been tested before (and been found negative?)
Here are some thoughts that Dr. Mikovitz communicated to a source which I have paraphrased. This is third hand information. (Obviously, this does not carry the weight of Dr. Mikovitz said, but I believe it to be an accurate reflection of her current thinking.) I have permission to post.
It is becoming more apparent that the virus in not being found in large numbers in the blood.
There have been over 300 verified positives so far.
The virus has been isolated from over 90% of the (antibody) serology positives.
When one person who was serology positive, but without detectable virus, was retested when symptoms were acute, the virus was then isolated.
It may be possible for some to develop antibodies after only being exposed to viral fragments, yet remain uninfected. (This is basically how a vaccine would work.) This could explain how some of the healthy population is positive.
Some who were expected to be positive have tested negative. Perhaps those who are the least sick and the most sick may not have free antibodies because it is bound in immune complexes.
It may be possible for some to have an immune defect that prevents them from expressing antibodies at all. They would then require culture testing, or possibly tissue biopsy to find the infection.
I have been trawling through the posts trying to find an answer to a query I have, particularly as the UK testing is now about to start. I would be grateful if some of our scientific boffins could clarify the following.
How likely is it that someone who has been severely ill for years, but much improved at the time of testing, will get a positive result, even if the illness was caused/associated with XMRV? As the virus is difficult to detect at the best of times, will a test subject in a period of remission still be likely to prove positive to the serology test? I would be grateful if this could be clarified.
Thanks.